{"name":"Shanghai WiseGain Medical Devices Co., Ltd.","slug":"shanghai-wisegain-medical-devices-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amlodipine, losartan potassium and hydrochlorothiazide","genericName":"Amlodipine, losartan potassium and hydrochlorothiazide","slug":"amlodipine-losartan-potassium-and-hydrochlorothiazide","indication":"Hypertension (essential hypertension management)","status":"phase_3"}]}],"pipeline":[{"name":"Amlodipine, losartan potassium and hydrochlorothiazide","genericName":"Amlodipine, losartan potassium and hydrochlorothiazide","slug":"amlodipine-losartan-potassium-and-hydrochlorothiazide","phase":"phase_3","mechanism":"This triple-combination antihypertensive reduces blood pressure through three complementary mechanisms: calcium channel blockade, angiotensin II receptor antagonism, and thiazide diuresis.","indications":["Hypertension (essential hypertension management)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFByMTlCRnp2UnBMYjBrYjBGN1JNakNtUC1Ed3pyZjV2ajFLLVZOXzE0MXN1WlZVSTF6TUZBUUtFdjdadHM3aFRNSE1NTS10Q3AxNC05Q0RVR2QwZU5aa0F6OXlqcGswVmc5NEZOdEw3VmZkX09LdDk0Tlh2Qk02RGM?oc=5","date":"2024-05-07","type":"regulatory","source":"MedTech Dive","summary":"Medtronic wins approval to sell renal denervation device in China - MedTech Dive","headline":"Medtronic wins approval to sell renal denervation device in China","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}